IBDEI0WE ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,42539,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,42540,0)
 ;;=E23.0^^127^1847^31
 ;;^UTILITY(U,$J,358.3,42540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42540,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,42540,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,42540,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,42541,0)
 ;;=E27.1^^127^1847^51
 ;;^UTILITY(U,$J,358.3,42541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42541,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,42541,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,42541,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,42542,0)
 ;;=E27.2^^127^1847^1
 ;;^UTILITY(U,$J,358.3,42542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42542,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,42542,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,42542,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,42543,0)
 ;;=E27.3^^127^1847^23
 ;;^UTILITY(U,$J,358.3,42543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42543,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,42543,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,42543,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,42544,0)
 ;;=E29.1^^127^1847^52
 ;;^UTILITY(U,$J,358.3,42544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42544,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,42544,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,42544,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,42545,0)
 ;;=E55.9^^127^1847^59
 ;;^UTILITY(U,$J,358.3,42545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42545,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,42545,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,42545,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,42546,0)
 ;;=E66.01^^127^1847^38
 ;;^UTILITY(U,$J,358.3,42546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42546,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,42546,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,42546,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,42547,0)
 ;;=E66.8^^127^1847^42
 ;;^UTILITY(U,$J,358.3,42547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42547,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,42547,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,42547,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,42548,0)
 ;;=E66.9^^127^1847^43
 ;;^UTILITY(U,$J,358.3,42548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42548,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,42548,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,42548,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,42549,0)
 ;;=E74.39^^127^1847^35
 ;;^UTILITY(U,$J,358.3,42549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42549,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,42549,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,42549,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,42550,0)
 ;;=E83.30^^127^1847^46
 ;;^UTILITY(U,$J,358.3,42550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42550,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,42550,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,42550,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,42551,0)
 ;;=E83.51^^127^1847^28
 ;;^UTILITY(U,$J,358.3,42551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42551,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,42551,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,42551,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,42552,0)
 ;;=E83.52^^127^1847^26
 ;;^UTILITY(U,$J,358.3,42552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42552,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,42552,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,42552,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,42553,0)
 ;;=E87.5^^127^1847^27
 ;;^UTILITY(U,$J,358.3,42553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42553,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,42553,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,42553,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,42554,0)
 ;;=E89.2^^127^1847^48
 ;;^UTILITY(U,$J,358.3,42554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42554,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,42554,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,42554,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,42555,0)
 ;;=E89.6^^127^1847^47
 ;;^UTILITY(U,$J,358.3,42555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42555,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,42555,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,42555,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,42556,0)
 ;;=L68.0^^127^1847^25
 ;;^UTILITY(U,$J,358.3,42556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42556,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,42556,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,42556,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,42557,0)
 ;;=M80.00XA^^127^1847^2
 ;;^UTILITY(U,$J,358.3,42557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42557,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Fx,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,42557,1,4,0)
 ;;=4^M80.00XA
 ;;^UTILITY(U,$J,358.3,42557,2)
 ;;=^5013363
 ;;^UTILITY(U,$J,358.3,42558,0)
 ;;=M81.0^^127^1847^3
 ;;^UTILITY(U,$J,358.3,42558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42558,1,3,0)
 ;;=3^Age-Related Osteoporosis w/o Fx
 ;;^UTILITY(U,$J,358.3,42558,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,42558,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,42559,0)
 ;;=M85.80^^127^1847^44
 ;;^UTILITY(U,$J,358.3,42559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42559,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,42559,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,42559,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,42560,0)
 ;;=N62.^^127^1847^24
 ;;^UTILITY(U,$J,358.3,42560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42560,1,3,0)
 ;;=3^Gynecomastia
 ;;^UTILITY(U,$J,358.3,42560,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,42560,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,42561,0)
 ;;=E10.43^^127^1847^6
 ;;^UTILITY(U,$J,358.3,42561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42561,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,42561,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,42561,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,42562,0)
 ;;=E10.59^^127^1847^4
 ;;^UTILITY(U,$J,358.3,42562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42562,1,3,0)
 ;;=3^DM Type 1 w/ Circulatory Complications
 ;;^UTILITY(U,$J,358.3,42562,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,42562,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,42563,0)
 ;;=E10.618^^127^1847^5
 ;;^UTILITY(U,$J,358.3,42563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42563,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,42563,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,42563,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,42564,0)
 ;;=E10.621^^127^1847^7
 ;;^UTILITY(U,$J,358.3,42564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42564,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,42564,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,42564,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,42565,0)
 ;;=E10.622^^127^1847^11
 ;;^UTILITY(U,$J,358.3,42565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42565,1,3,0)
 ;;=3^DM Type 1 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,42565,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,42565,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,42566,0)
 ;;=E10.65^^127^1847^10
 ;;^UTILITY(U,$J,358.3,42566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42566,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycermia
 ;;^UTILITY(U,$J,358.3,42566,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,42566,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,42567,0)
 ;;=E10.39^^127^1847^9
 ;;^UTILITY(U,$J,358.3,42567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42567,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complications NEC
 ;;^UTILITY(U,$J,358.3,42567,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,42567,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,42568,0)
 ;;=E66.3^^127^1847^45
 ;;^UTILITY(U,$J,358.3,42568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42568,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,42568,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,42568,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,42569,0)
 ;;=E89.1^^127^1847^49
 ;;^UTILITY(U,$J,358.3,42569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42569,1,3,0)
 ;;=3^Postprocedural Hypoinsulinemia
 ;;^UTILITY(U,$J,358.3,42569,1,4,0)
 ;;=4^E89.1
 ;;^UTILITY(U,$J,358.3,42569,2)
 ;;=^5003036
 ;;^UTILITY(U,$J,358.3,42570,0)
 ;;=H40.9^^127^1848^9
 ;;^UTILITY(U,$J,358.3,42570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42570,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,42570,1,4,0)
 ;;=4^H40.9
 ;;^UTILITY(U,$J,358.3,42570,2)
 ;;=^5005931
 ;;^UTILITY(U,$J,358.3,42571,0)
 ;;=H26.9^^127^1848^5
 ;;^UTILITY(U,$J,358.3,42571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42571,1,3,0)
 ;;=3^Cataract,Unspec
 ;;^UTILITY(U,$J,358.3,42571,1,4,0)
 ;;=4^H26.9
 ;;^UTILITY(U,$J,358.3,42571,2)
 ;;=^5005363
 ;;^UTILITY(U,$J,358.3,42572,0)
 ;;=H10.9^^127^1848^8
 ;;^UTILITY(U,$J,358.3,42572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42572,1,3,0)
 ;;=3^Conjunctivitis,Unspec
 ;;^UTILITY(U,$J,358.3,42572,1,4,0)
 ;;=4^H10.9
 ;;^UTILITY(U,$J,358.3,42572,2)
 ;;=^5004716
 ;;^UTILITY(U,$J,358.3,42573,0)
 ;;=H11.32^^127^1848^6
 ;;^UTILITY(U,$J,358.3,42573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42573,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,42573,1,4,0)
 ;;=4^H11.32
 ;;^UTILITY(U,$J,358.3,42573,2)
 ;;=^5004783
 ;;^UTILITY(U,$J,358.3,42574,0)
 ;;=H11.31^^127^1848^7
 ;;^UTILITY(U,$J,358.3,42574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42574,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,42574,1,4,0)
 ;;=4^H11.31
 ;;^UTILITY(U,$J,358.3,42574,2)
 ;;=^5004782
 ;;^UTILITY(U,$J,358.3,42575,0)
 ;;=H01.002^^127^1848^3
 ;;^UTILITY(U,$J,358.3,42575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42575,1,3,0)
 ;;=3^Blepharitis Unspec,Right Lower Eyelid
 ;;^UTILITY(U,$J,358.3,42575,1,4,0)
 ;;=4^H01.002
 ;;^UTILITY(U,$J,358.3,42575,2)
 ;;=^5004239
 ;;^UTILITY(U,$J,358.3,42576,0)
 ;;=H01.004^^127^1848^2
